table of content
1 Introduction to Research & Analysis Reports
1.1 Endothelin Antagonists Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Endothelin Antagonists Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Endothelin Antagonists Therapeutics Overall Market Size
2.1 Global Endothelin Antagonists Therapeutics Market Size: 2023 VS 2030
2.2 Global Endothelin Antagonists Therapeutics Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Endothelin Antagonists Therapeutics Sales: 2019-2030
3 Company Landscape
3.1 Top Endothelin Antagonists Therapeutics Players in Global Market
3.2 Top Global Endothelin Antagonists Therapeutics Companies Ranked by Revenue
3.3 Global Endothelin Antagonists Therapeutics Revenue by Companies
3.4 Global Endothelin Antagonists Therapeutics Sales by Companies
3.5 Global Endothelin Antagonists Therapeutics Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Endothelin Antagonists Therapeutics Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Endothelin Antagonists Therapeutics Product Type
3.8 Tier 1, Tier 2 and Tier 3 Endothelin Antagonists Therapeutics Players in Global Market
3.8.1 List of Global Tier 1 Endothelin Antagonists Therapeutics Companies
3.8.2 List of Global Tier 2 and Tier 3 Endothelin Antagonists Therapeutics Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Endothelin Antagonists Therapeutics Market Size Markets, 2023 & 2030
4.1.2 Oral
4.1.3 Parenteral
4.2 By Type - Global Endothelin Antagonists Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Endothelin Antagonists Therapeutics Revenue, 2019-2024
4.2.2 By Type - Global Endothelin Antagonists Therapeutics Revenue, 2025-2030
4.2.3 By Type - Global Endothelin Antagonists Therapeutics Revenue Market Share, 2019-2030
4.3 By Type - Global Endothelin Antagonists Therapeutics Sales & Forecasts
4.3.1 By Type - Global Endothelin Antagonists Therapeutics Sales, 2019-2024
4.3.2 By Type - Global Endothelin Antagonists Therapeutics Sales, 2025-2030
4.3.3 By Type - Global Endothelin Antagonists Therapeutics Sales Market Share, 2019-2030
4.4 By Type - Global Endothelin Antagonists Therapeutics Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Endothelin Antagonists Therapeutics Market Size, 2023 & 2030
5.1.2 Cardiovascular Diseases
5.1.3 Scleroderma
5.1.4 Other
5.2 By Application - Global Endothelin Antagonists Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Endothelin Antagonists Therapeutics Revenue, 2019-2024
5.2.2 By Application - Global Endothelin Antagonists Therapeutics Revenue, 2025-2030
5.2.3 By Application - Global Endothelin Antagonists Therapeutics Revenue Market Share, 2019-2030
5.3 By Application - Global Endothelin Antagonists Therapeutics Sales & Forecasts
5.3.1 By Application - Global Endothelin Antagonists Therapeutics Sales, 2019-2024
5.3.2 By Application - Global Endothelin Antagonists Therapeutics Sales, 2025-2030
5.3.3 By Application - Global Endothelin Antagonists Therapeutics Sales Market Share, 2019-2030
5.4 By Application - Global Endothelin Antagonists Therapeutics Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Endothelin Antagonists Therapeutics Market Size, 2023 & 2030
6.2 By Region - Global Endothelin Antagonists Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Endothelin Antagonists Therapeutics Revenue, 2019-2024
6.2.2 By Region - Global Endothelin Antagonists Therapeutics Revenue, 2025-2030
6.2.3 By Region - Global Endothelin Antagonists Therapeutics Revenue Market Share, 2019-2030
6.3 By Region - Global Endothelin Antagonists Therapeutics Sales & Forecasts
6.3.1 By Region - Global Endothelin Antagonists Therapeutics Sales, 2019-2024
6.3.2 By Region - Global Endothelin Antagonists Therapeutics Sales, 2025-2030
6.3.3 By Region - Global Endothelin Antagonists Therapeutics Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Endothelin Antagonists Therapeutics Revenue, 2019-2030
6.4.2 By Country - North America Endothelin Antagonists Therapeutics Sales, 2019-2030
6.4.3 US Endothelin Antagonists Therapeutics Market Size, 2019-2030
6.4.4 Canada Endothelin Antagonists Therapeutics Market Size, 2019-2030
6.4.5 Mexico Endothelin Antagonists Therapeutics Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Endothelin Antagonists Therapeutics Revenue, 2019-2030
6.5.2 By Country - Europe Endothelin Antagonists Therapeutics Sales, 2019-2030
6.5.3 Germany Endothelin Antagonists Therapeutics Market Size, 2019-2030
6.5.4 France Endothelin Antagonists Therapeutics Market Size, 2019-2030
6.5.5 U.K. Endothelin Antagonists Therapeutics Market Size, 2019-2030
6.5.6 Italy Endothelin Antagonists Therapeutics Market Size, 2019-2030
6.5.7 Russia Endothelin Antagonists Therapeutics Market Size, 2019-2030
6.5.8 Nordic Countries Endothelin Antagonists Therapeutics Market Size, 2019-2030
6.5.9 Benelux Endothelin Antagonists Therapeutics Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Endothelin Antagonists Therapeutics Revenue, 2019-2030
6.6.2 By Region - Asia Endothelin Antagonists Therapeutics Sales, 2019-2030
6.6.3 China Endothelin Antagonists Therapeutics Market Size, 2019-2030
6.6.4 Japan Endothelin Antagonists Therapeutics Market Size, 2019-2030
6.6.5 South Korea Endothelin Antagonists Therapeutics Market Size, 2019-2030
6.6.6 Southeast Asia Endothelin Antagonists Therapeutics Market Size, 2019-2030
6.6.7 India Endothelin Antagonists Therapeutics Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Endothelin Antagonists Therapeutics Revenue, 2019-2030
6.7.2 By Country - South America Endothelin Antagonists Therapeutics Sales, 2019-2030
6.7.3 Brazil Endothelin Antagonists Therapeutics Market Size, 2019-2030
6.7.4 Argentina Endothelin Antagonists Therapeutics Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Endothelin Antagonists Therapeutics Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Endothelin Antagonists Therapeutics Sales, 2019-2030
6.8.3 Turkey Endothelin Antagonists Therapeutics Market Size, 2019-2030
6.8.4 Israel Endothelin Antagonists Therapeutics Market Size, 2019-2030
6.8.5 Saudi Arabia Endothelin Antagonists Therapeutics Market Size, 2019-2030
6.8.6 UAE Endothelin Antagonists Therapeutics Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Gilead Sciences, Inc
7.1.1 Gilead Sciences, Inc Company Summary
7.1.2 Gilead Sciences, Inc Business Overview
7.1.3 Gilead Sciences, Inc Endothelin Antagonists Therapeutics Major Product Offerings
7.1.4 Gilead Sciences, Inc Endothelin Antagonists Therapeutics Sales and Revenue in Global (2019-2024)
7.1.5 Gilead Sciences, Inc Key News & Latest Developments
7.2 Sun Pharmaceutical Industries Ltd
7.2.1 Sun Pharmaceutical Industries Ltd Company Summary
7.2.2 Sun Pharmaceutical Industries Ltd Business Overview
7.2.3 Sun Pharmaceutical Industries Ltd Endothelin Antagonists Therapeutics Major Product Offerings
7.2.4 Sun Pharmaceutical Industries Ltd Endothelin Antagonists Therapeutics Sales and Revenue in Global (2019-2024)
7.2.5 Sun Pharmaceutical Industries Ltd Key News & Latest Developments
7.3 Lupin
7.3.1 Lupin Company Summary
7.3.2 Lupin Business Overview
7.3.3 Lupin Endothelin Antagonists Therapeutics Major Product Offerings
7.3.4 Lupin Endothelin Antagonists Therapeutics Sales and Revenue in Global (2019-2024)
7.3.5 Lupin Key News & Latest Developments
7.4 Zydus Group
7.4.1 Zydus Group Company Summary
7.4.2 Zydus Group Business Overview
7.4.3 Zydus Group Endothelin Antagonists Therapeutics Major Product Offerings
7.4.4 Zydus Group Endothelin Antagonists Therapeutics Sales and Revenue in Global (2019-2024)
7.4.5 Zydus Group Key News & Latest Developments
7.5 Endo International plc
7.5.1 Endo International plc Company Summary
7.5.2 Endo International plc Business Overview
7.5.3 Endo International plc Endothelin Antagonists Therapeutics Major Product Offerings
7.5.4 Endo International plc Endothelin Antagonists Therapeutics Sales and Revenue in Global (2019-2024)
7.5.5 Endo International plc Key News & Latest Developments
7.6 Mylan NV
7.6.1 Mylan NV Company Summary
7.6.2 Mylan NV Business Overview
7.6.3 Mylan NV Endothelin Antagonists Therapeutics Major Product Offerings
7.6.4 Mylan NV Endothelin Antagonists Therapeutics Sales and Revenue in Global (2019-2024)
7.6.5 Mylan NV Key News & Latest Developments
7.7 Teva Pharmaceutical Industries Ltd
7.7.1 Teva Pharmaceutical Industries Ltd Company Summary
7.7.2 Teva Pharmaceutical Industries Ltd Business Overview
7.7.3 Teva Pharmaceutical Industries Ltd Endothelin Antagonists Therapeutics Major Product Offerings
7.7.4 Teva Pharmaceutical Industries Ltd Endothelin Antagonists Therapeutics Sales and Revenue in Global (2019-2024)
7.7.5 Teva Pharmaceutical Industries Ltd Key News & Latest Developments
7.8 Sigmapharm Laboratories , LLC
7.8.1 Sigmapharm Laboratories , LLC Company Summary
7.8.2 Sigmapharm Laboratories , LLC Business Overview
7.8.3 Sigmapharm Laboratories , LLC Endothelin Antagonists Therapeutics Major Product Offerings
7.8.4 Sigmapharm Laboratories , LLC Endothelin Antagonists Therapeutics Sales and Revenue in Global (2019-2024)
7.8.5 Sigmapharm Laboratories , LLC Key News & Latest Developments
7.9 Alembic Pharmaceuticals Limited
7.9.1 Alembic Pharmaceuticals Limited Company Summary
7.9.2 Alembic Pharmaceuticals Limited Business Overview
7.9.3 Alembic Pharmaceuticals Limited Endothelin Antagonists Therapeutics Major Product Offerings
7.9.4 Alembic Pharmaceuticals Limited Endothelin Antagonists Therapeutics Sales and Revenue in Global (2019-2024)
7.9.5 Alembic Pharmaceuticals Limited Key News & Latest Developments
7.10 Hikma Pharmaceuticals PLC
7.10.1 Hikma Pharmaceuticals PLC Company Summary
7.10.2 Hikma Pharmaceuticals PLC Business Overview
7.10.3 Hikma Pharmaceuticals PLC Endothelin Antagonists Therapeutics Major Product Offerings
7.10.4 Hikma Pharmaceuticals PLC Endothelin Antagonists Therapeutics Sales and Revenue in Global (2019-2024)
7.10.5 Hikma Pharmaceuticals PLC Key News & Latest Developments
7.11 Amneal Pharmaceuticals LLC
7.11.1 Amneal Pharmaceuticals LLC Company Summary
7.11.2 Amneal Pharmaceuticals LLC Endothelin Antagonists Therapeutics Business Overview
7.11.3 Amneal Pharmaceuticals LLC Endothelin Antagonists Therapeutics Major Product Offerings
7.11.4 Amneal Pharmaceuticals LLC Endothelin Antagonists Therapeutics Sales and Revenue in Global (2019-2024)
7.11.5 Amneal Pharmaceuticals LLC Key News & Latest Developments
7.12 AstraZeneca
7.12.1 AstraZeneca Company Summary
7.12.2 AstraZeneca Endothelin Antagonists Therapeutics Business Overview
7.12.3 AstraZeneca Endothelin Antagonists Therapeutics Major Product Offerings
7.12.4 AstraZeneca Endothelin Antagonists Therapeutics Sales and Revenue in Global (2019-2024)
7.12.5 AstraZeneca Key News & Latest Developments
7.13 Johnsons & Johnsons Private limited
7.13.1 Johnsons & Johnsons Private limited Company Summary
7.13.2 Johnsons & Johnsons Private limited Endothelin Antagonists Therapeutics Business Overview
7.13.3 Johnsons & Johnsons Private limited Endothelin Antagonists Therapeutics Major Product Offerings
7.13.4 Johnsons & Johnsons Private limited Endothelin Antagonists Therapeutics Sales and Revenue in Global (2019-2024)
7.13.5 Johnsons & Johnsons Private limited Key News & Latest Developments
7.14 GSK Plc
7.14.1 GSK Plc Company Summary
7.14.2 GSK Plc Business Overview
7.14.3 GSK Plc Endothelin Antagonists Therapeutics Major Product Offerings
7.14.4 GSK Plc Endothelin Antagonists Therapeutics Sales and Revenue in Global (2019-2024)
7.14.5 GSK Plc Key News & Latest Developments
8 Global Endothelin Antagonists Therapeutics Production Capacity, Analysis
8.1 Global Endothelin Antagonists Therapeutics Production Capacity, 2019-2030
8.2 Endothelin Antagonists Therapeutics Production Capacity of Key Manufacturers in Global Market
8.3 Global Endothelin Antagonists Therapeutics Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Endothelin Antagonists Therapeutics Supply Chain Analysis
10.1 Endothelin Antagonists Therapeutics Industry Value Chain
10.2 Endothelin Antagonists Therapeutics Upstream Market
10.3 Endothelin Antagonists Therapeutics Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Endothelin Antagonists Therapeutics Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
